TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
Posted May 26, 2021

LONDON, UK—ACG appointed Daniel Illmer as design head of encapsulation and Afsaneh Nakhavoli as design head of tableting at the company’s R&D facility in Germany. In his role, Illmer will manage product development, maintenance, improvements, and redesign for encapsulation. Meanwhile, Nakhavoli will oversee innovation and product development for tableting.

Posted May 24, 2021

DANIA BEACH, FL—CapsCanada has launched a liquid-filled hard capsule manufacturing service to support the entire manufacturing process, from formulation and development through full-scale production in North America. Production will be done at a dedicated Health Canada-approved facility in Canada that has a full analytical lab, licensing for controlled drugs and substances including narcotics, and a choice of blister or bottle packaging. The facility is waiting for FDA approval for the manufacture and testing of solid oral dosage forms.

Posted May 21, 2021

SHIRWAL, INDIA—ACG has added a lab for process development in Shirwal, India. The AGG Laboratories facility will provide customers and partners with a research, development, testing, and training environment dedicated to the collaborative exploration of all aspects of oral solid dosage manufacturing. The new lab allows ACG clients to explore and solve their manufacturing needs and challenges in a dedicated, state-of-the-art space. The facility also answers a growing customer need for training and assistance with clinical trials and development projects.

Posted May 20, 2021

BEND, OR—Lonza has expanded its solid form selection services at the company’s Center of Excellence for bioavailability site in Bend, OR. The solid form services will enhance the company’s SimpliFiH Solutions first-in-human services, intended to speed the advancement of small molecules, and allow the company to meet accelerated timelines for increasingly complex molecules. The company’s comprehensive solid form services include form and salt/cocrystal screening, solid state characterization, chemical composition, solubility and dissolution, and powder properties.

Posted May 19, 2021

SOMERSET, NJ—Catalent has signed an agreement with Canadian biotech company Cybin to apply Catalent’s Zydis orally disintegrating tablet (ODT) technology to deliver Cybin’s novel deuterated tryptamine, a potential therapy for treatment-resistant psychiatric disorders. Zydis creates a freeze-dried tablet that rapidly dissolves in the mouth without water, which would allow pre-gastric delivery of deuterated tryptamine and prevent first pass metabolism, improving the drug’s pharmacokinetic profile. The project commenced in April and will involve feasibility studies of ODT doses with varying quantities of deuterated tryptamine along with other excipients.

Posted April 23, 2021

HAMBURG, Germany—iF International Forum Design awarded ACG the 2021 design award for its Karton X packaging unit. This award recognizes that the product exhibits superior innovation and exemplary design. The high-speed pharmaceutical cartoner can package up to 300 items per minute, including blisters, bottles, tubes, vials, or ampoules in secondary packaging.